Topics

Vifor Pharma Appoints New Chief Medical Officer and Announces Changes to Executive Committee

01:00 EDT 11 Sep 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Regulatory News: Vifor Pharma today announced changes to its management. Dr Klaus Henning Jensen will join the company as Chief Medical Officer and Member of the Executive Committee in January 2020. Dario Eklund, Chief Commercial Officer and member of t...

Other Sources for this Article

Media Relations
Nathalie Ponnier
Global Head Corporate Communications
+41 58 852 90 16
media@viforpharma.com

Investor Relations
Julien Vignot
Head of Investor Relations
+41 58 851 66 90
investors@viforpharma.com

NEXT ARTICLE

More From BioPortfolio on "Vifor Pharma Appoints New Chief Medical Officer and Announces Changes to Executive Committee "

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...